| Literature DB >> 23515026 |
Eleanor R Gaunt1, Qifeng Zhang2, Winsome Cheung1, Michael J O Wakelam2, Andrew M L Lever1, Ulrich Desselberger1.
Abstract
Rotaviruses (RVs) cause acute gastroenteritis in infants and young children, and are globally distributed. Within the infected host cell, RVs establish replication complexes in viroplasms ('viral factories') to which lipid droplet organelles are recruited. To further understand this recently discovered phenomenon, the lipidomes of RV-infected and uninfected MA104 cells were investigated. Cell lysates were subjected to equilibrium ultracentrifugation through iodixanol gradients. Fourteen different classes of lipids were differentiated by mass spectrometry. The concentrations of virtually all lipids were elevated in RV-infected cells. Fractions of low density (1.11-1.15 g ml⁻¹), in which peaks of the RV dsRNA genome and lipid droplet- and viroplasm-associated proteins were observed, contained increased amounts of lipids typically found concentrated in the cellular organelle lipid droplets, confirming the close interaction of lipid droplets with viroplasms. A decrease in the ratio of the amounts of surface to internal components of lipid droplets upon RV infection suggested that the lipid droplet-viroplasm complexes became enlarged.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23515026 PMCID: PMC3709634 DOI: 10.1099/vir.0.049635-0
Source DB: PubMed Journal: J Gen Virol ISSN: 0022-1317 Impact factor: 3.891
Fig. 1. Agarose gel of RV-infected cell lysate fractions 7–12. Densities of fractions (g ml−1) are indicated at the bottom of each lane. RV RNA segment numbers are indicated to the left of the image (Kalica ).
Total lipid content by species in RV-infected vs uninfected cells
Unin, Uninfected cells; Unin(ab), uninfected cell lysate treated with anti-mitochondrial antibodies; In, infected cells; In(ab), infected cells treated with anti-mitochondrial antibodies.
Cer, Ceramide; CL, cardiolipin; FFA, free fatty acids; LPC, lysophosphatidylcholine; PA, phosphatidic acid; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PG, phosphatidylglycerol; PI, phosphatidylinositol; PS, phosphatidylserine; SM, sphingomyelin; TAG, triacylglycerol; CE, cholesterol ester; CH, cholesterol.
| Lipid class | Total detected (ng per fraction) | Total lipid (%)* | ||||||
| Unin | In | Unin(ab) | In(ab) | Unin | In | Unin(ab) | In(ab) | |
| Cer | 389.1 | 590.4 | 156.1 | 256.9 | 1.82 | 2.31 | 0.92 | 1.07 |
| CL | 628.3 | 1 398.9 | 310.8 | 423.2 | 2.93 | 5.47 | 1.83 | 1.76 |
| FFA | 4 512.0 | 6 120.9 | 4 727.3 | 5 639.4 | 21.06 | 23.94 | 27.88 | 23.40 |
| LPC | 125.4 | 67.3 | 31.2 | 63.1 | 0.59 | 0.26 | 0.18 | 0.26 |
| PA | 68.4 | 93.4 | 74.6 | 84.8 | 0.32 | 0.37 | 0.44 | 0.35 |
| PC | 3 686.5 | 3 057.0 | 2 623.6 | 3 573.2 | 17.21 | 11.96 | 15.48 | 14.83 |
| PE | 1 373.2 | 1 258.3 | 1 468.7 | 2 524.8 | 6.41 | 4.92 | 8.66 | 10.48 |
| PG | 45.6 | 112.4 | 16.7 | 23.5 | 0.21 | 0.44 | 0.10 | 0.10 |
| PI | 3 441.3 | 3 781.0 | 2 567.3 | 3 612.2 | 16.07 | 14.79 | 15.14 | 14.99 |
| PS | 1 170.4 | 1 451.8 | 913.5 | 1 361.7 | 5.46 | 5.68 | 5.39 | 5.65 |
| SM | 663.1 | 875.5 | 480.2 | 758.3 | 3.10 | 3.42 | 2.83 | 3.15 |
| TAG | 296.7 | 398.5 | 137.1 | 137.0 | 1.39 | 1.56 | 0.81 | 0.57 |
| CE | 802.6 | 853.3 | 644.2 | 951.3 | 3.75 | 3.34 | 3.80 | 3.95 |
| CH | 4 217.4 | 5 508.1 | 2 801.6 | 4 685.4 | 19.69 | 21.54 | 16.53 | 19.45 |
| Cer | 483.0 | 529.6 | 320.5 | 362.8 | 1.11 | 1.24 | 0.95 | 0.95 |
| CL | 3 801.9 | 2 478.3 | 2 188.5 | 1 814.7 | 8.76 | 5.80 | 6.46 | 4.73 |
| FFA | 6 750.2 | 9 310.3 | 5 932.9 | 8 821.5 | 15.55 | 21.78 | 17.50 | 23.01 |
| LPC | 178.1 | 209.9 | 83.1 | 90.3 | 0.41 | 0.49 | 0.25 | 0.24 |
| PA | 127.2 | 205.6 | 89.9 | 161.5 | 0.29 | 0.48 | 0.27 | 0.42 |
| PC | 4 528.2 | 4 323.4 | 4 136.1 | 5 201.9 | 10.43 | 10.11 | 12.20 | 13.57 |
| PE | 3 013.2 | 2 792.0 | 1 962.0 | 2 335.0 | 6.94 | 6.53 | 5.79 | 6.09 |
| PG | 36.7 | 29.4 | 41.9 | 24.4 | 0.08 | 0.07 | 0.12 | 0.06 |
| PI | 9 250.4 | 8 844.2 | 6 633.1 | 7 550.3 | 21.31 | 20.69 | 19.57 | 19.70 |
| PS | 2 867.6 | 2 801.3 | 2 322.4 | 2 729.4 | 6.61 | 6.55 | 6.85 | 7.12 |
| SM | 1 729.6 | 1 870.9 | 1 222.2 | 1 232.4 | 3.98 | 4.38 | 3.61 | 3.22 |
| TAG | 315.3 | 214.4 | 305.5 | 295.9 | 0.73 | 0.50 | 0.90 | 0.77 |
| CE | 1 856.1 | 1 803.9 | 1 580.0 | 1 534.9 | 4.28 | 4.22 | 4.66 | 4.00 |
| CH | 8 469.5 | 7 338.3 | 7 081.9 | 6 176.5 | 19.51 | 17.16 | 20.89 | 16.11 |
Each lipid class expressed as a percentage of the total amount of lipid detected.
Fig. 2. Western blot of subcellular fractions for detection of VP1 (125 kDa) and ADRP (48 kDa). Densities of fractions (g ml−1) are indicated at the head of each lane.
Percentage increase in each lipid class during RV infection
| Lipid class | Experiment 1 | Experiment 2 | Mean post-infection as % of non-infection AM± | |||
| Post-infection as % of non-infection | Post-infection as % of non-infection | |||||
| Untreated | Antibody treated | Untreated | Antibody treated | Untreated | Antibody treated | |
| Cer | 151.7 | 164.6 | 109.7 | 113.2 | ||
| CL | 222.6 | 136.2 | 65.2 | 82.9 | 143.9±78.3 | 109.5±27.7 |
| FFA | 135.7 | 119.3 | 137.9 | 148.7 | ||
| LPC | 53.7 | 202.3 | 117.9 | 108.6 | 85.8±32.1 | |
| PA | 136.4 | 113.7 | 161.7 | 179.7 | ||
| PC | 82.9 | 136.2 | 95.5 | 125.8 | 89.2±7.3 | |
| PE | 91.6 | 171.9 | 92.7 | 119.0 | 92.1±0.6 | |
| PI | 109.9 | 140.7 | 95.6 | 113.8 | 102.7±7.2 | |
| PG | 246.8 | 140.9 | 80.2 | 58.1 | 163.5±83.3 | 99.5±41.4 |
| PS | 124.0 | 149.1 | 97.7 | 117.5 | 110.9±13.1 | |
| SM | 132.0 | 157.9 | 108.2 | 100.8 | ||
| TAG | 134.3 | 99.9 | 68.0 | 96.9 | 101.2±33.1 | 98.4±1.5 |
| CE | 106.3 | 147.7 | 97.2 | 97.2 | 101.8±4.6 | 121.8±25.9 |
| CH | 130.6 | 167.2 | 86.6 | 87.2 | 108.6±22.0 | 127.7±40.0 |
AM, Arithmetic mean; signficant increases are indicated in bold.
Ratio of infected : uninfected of the major lipid droplet components in corresponding fractions of cell lysate (experiment 1)
Ratios are given for untreated fractions and fractions which were treated with anti-mitochondrial antibodies (ab). Arithmetic mean±SEM values are calculated for two (three for PA) most abundant species in a lipid class. Most abundant species used for calculations: Cer: 16 : 0, 24 : 1; SM: 16 : 0, 18 : 0; TAG 50 : 1, 52 : 2; PI: 36 : 2, 38 : 2; PA: 34 : 1, 36 : 2, 36 : 1; CL: 68 : 4, 70 : 4 (Appendix S1). Highest ratios in fractions are indicated in bold.
| Experiment 1 lipid class | Fraction | |||||||
| 4 | 5 | 6 | 7 | 4(ab) | 5(ab) | 6(ab) | 7(ab) | |
| Cer | 0.87±0.11 | 2.37±1.00 | 0.17±0.17 | 1.48±0.2 | 1.22±0.14 | 2.67±0.67 | ||
| SM | 0.45±0.03 | 1.38±0.09 | 0.23±0.20 | 0.92±0.03 | 1.46±0.06 | 2.20±0.27 | ||
| TAG | 0.09±0 | 1.27±0.01 | 0.30±0.16 | 0.39±0.03 | 1.00±0.04 | 2.12±0.08 | ||
| PI | 0.28±0.01 | 1.38±0.03 | 0.71±0.01 | 0.73±0.03 | 1.17±0.03 | 1.85±0.05 | ||
| PA | 0.40±0.14 | 1.17±0.06 | 0.17±0.03 | 0.97±0.78 | 1.69±0.75 | 2.06±0.43 | ||
| CL | 0 | 3.38±0.24 | 4.2±2.2 | – | – | 1.22±0.12 | 1.30±0.14 | – |
| Density (uninf) | 1.093 | 1.117 | 1.146 | 1.176 | 1.086 | 1.120 | 1.151 | 1.184 |
| Density (inf) | 1.072 | 1.113 | 1.150 | 1.177 | 1.068 | 1.110 | 1.132 | 1.179 |
Ratio of infected : uninfected of the major lipid droplet components in corresponding fractions of cell lysate (experiment 2)
Ratios are given for untreated fractions and fractions which were treated with anti-mitochondrial antibodies (ab). Arithmetic mean±sem values are calculated for the two (three for PA) most abundant species in a lipid class. Most abundant species used for calculations: Cer: 16 : 0, 24 : 1; SM: 16 : 0, 18 : 0; TAG 50 : 1, 52 : 2; PI: 36 : 2, 38 : 2; PA: 34 : 1, 36 : 2, 36 : 1; CL: 68 : 4, 70 : 4 (Appendix S1).
| Experiment 2 lipid class | Fraction | |||||||
| 6 | 7 | 8 | 9 | 6(ab) | 7(ab) | 8(ab) | 9(ab) | |
| Cer | 0.80±0.01 | 0.71±0.11 | 0.40±0.13 | 0.86±0.03 | 0.87±0.05 | 1.17±0.13 | ||
| SM | 0.92±0.01 | 0.80±0.02 | 0.52±0.02 | 0.79±0.03 | 0.83±0.04 | 1.78±0.46 | ||
| TAG | 0.62±0.01 | 0.78±0.05 | 0.56±0.04 | 0.65±0.04 | 1.87±0.13 | 1.12±0.12 | ||
| PI | 0.53±0.02 | 0.57±0.03 | 0.30±0.01 | 0.69±0.03 | 0.89±0.03 | 1.12±0.03 | ||
| PA | 0.91±0.24 | 0.88±0.31 | 0.97±0.43 | 0.96±0.22 | 0.76±0.39 | 3.98±2.22 | ||
| CL | 0.13±0.0 | 0.28±0.01 | 1.21±0.01 | 0.32±0.01 | 0.27±0.01 | 0.60±0.07 | 0.70±0.10 | 1.64±0.01 |
| Density (uninf) | 1.094 | 1.107 | 1.112 | 1.138 | 1.098 | 1.112 | 1.125 | 1.140 |
| Density (inf) | 1.094 | 1.107 | 1.120 | 1.137 | 1.103 | 1.115 | 1.128 | 1.138 |
Lipid components (in ng) in gradient fractions containing peak amount of RV dsRNAs
| (a) Experiment 1: fractions 5+6 | ||||
| Untreated | Antibody treated* | |||
| Lipid class | Uninfected | Infected | Uninfected | Infected |
| Cer | 226 | 470 | 116 | 191 |
| LPC | 109 | 63 | 24 | 51 |
| PA | 41 | 84 | 40 | 69 |
| PC | 2220 | 2390 | 1749 | 2643 |
| PE | 752 | 1034 | 1060 | 2084 |
| PG | 31 | 108 | 14 | 21 |
| PI | 2296 | 3419 | 1962 | 3072 |
| PS | 704 | 1230 | 654 | 1106 |
| SM | 395 | 763 | 327 | 607 |
| Subtotal of phospholipids | 6774 | 9561 | 5946 | 9844 |
| TAG | 156 | 352 | 84 | 111 |
| CE | 477 | 692 | 416 | 730 |
| CH | 2540 | 4588 | 1835 | 3569 |
| Subtotal of TAG+CE+CH | 3173 | 5632 | 2335 | 3569 |
| Ratio of subtotals† | 2.13 | 1.70 | 2.55 | 2.23 |
Anti-mitochondrial antibody treated.
[Subtotal of phospholipids/subtotal of (TAG+CE+CH)].
Ratio of CE : TAG in RV-infected and uninfected cells, without and with anti-mitochondrial antibody treatment
Means were not significantly different (t-test, P>0.05). Exp., Experiments.
| CE : TAG ratio | |||||||
| Untreated | Antibody treated | Overall | |||||
| Infection status | Exp. 1 | Exp. 2 | Mean± | Exp. 1 | Exp. 2 | Mean± | Mean± |
| 0.33 | 0.22 | 0.28±0.06 | 0.20 | 0.17 | 0.19±0.02 | 0.23±0.07 | |
| 0.51 | 0.27 | 0.39±0.12 | 0.15 | 0.25 | 0.20±0.05 | 0.30±0.15 | |